Ahmadian A, Mizzi A, Banasiak M, Downes K, Camporesi E M, Thompson Sullebarger J, Vasan R, Mangar D, van Loveren H R, Agazzi S
Department of Neurosurgery, University of South Florida, Tampa, Florida.
Department of Anesthesia and Intensive Care, San Raffaele Scientific Institute, Milan, Italy.
Heart Lung Vessel. 2013;5(3):168-78.
Cardiac manifestations of intracranial subarachnoid hemorrhage patients include mild electrocardiogram variability, reversible left ventricular dysfunction (Takotsubo), non-ST elevation myocardial infarction, ST-elevation myocardial infarction and cardiac arrest, but their clinical relevance is unclear. The aim of the present study was to categorize the relative frequency of different cardiac abnormalities in patients with subarachnoid hemorrhage and determine the influence of each abnormality on outcome.
A retrospective review of 617 consecutive patients who presented with non-traumatic aneurysmal subarachnoid hemorrhage at our institution was performed. A cohort of 87 (14.1%) patients who required concomitantly cardiological evaluation was selected for subgroup univariate and multi-variable analysis of radiographic, clinical and cardiac data.
Cardiac complications included myocardial infarction arrhythmia and congestive heart failure in 47%, 63% and 31% of the patients respectively. The overall mortality of our cohort (23%) was similar to that of national inpatient databases. In our cohort a high World Federation of Neurosurgical Surgeons grading scale and a troponin level >1.0 mcg/L were associated with a 33 times and 10 times higher risk of death respectively.
Among patients suffering from cardiac events at the time of aneurysmal subarachnoid hemorrhage, those with myocardial infarction and in particular those with a troponin level greater than 1.0 mcg/L had a 10 times increased risk of death.
颅内蛛网膜下腔出血患者的心脏表现包括轻度心电图变化、可逆性左心室功能障碍(Takotsubo综合征)、非ST段抬高型心肌梗死、ST段抬高型心肌梗死和心脏骤停,但其临床相关性尚不清楚。本研究的目的是对蛛网膜下腔出血患者不同心脏异常的相对频率进行分类,并确定每种异常对预后的影响。
对我院连续617例非创伤性动脉瘤性蛛网膜下腔出血患者进行回顾性研究。选择87例(14.1%)需要同时进行心脏评估的患者,对影像学、临床和心脏数据进行亚组单变量和多变量分析。
心脏并发症包括心肌梗死、心律失常和充血性心力衰竭,分别占患者的47%、63%和31%。我们队列的总体死亡率(23%)与国家住院数据库相似。在我们的队列中,世界神经外科医师联合会高分级量表和肌钙蛋白水平>1.0 mcg/L分别与死亡风险高33倍和10倍相关。
在动脉瘤性蛛网膜下腔出血时发生心脏事件的患者中,发生心肌梗死的患者,尤其是肌钙蛋白水平大于1.0 mcg/L的患者,死亡风险增加10倍。